Nkarta (NKTX) Stock Forecast, Price Target & Predictions
NKTX Stock Forecast
Nkarta (NKTX) stock forecast, based on 11 Wall Street analysts, predicts a 12-month average price target of $21.60, with a high of $36.00 and a low of $15.00. This represents a 1030.89% increase from the last price of $1.91.
NKTX Stock Rating
Nkarta stock's rating consensus is Buy, based on 11 Wall Street analysts. The breakdown includes 1 Strong Buy (9.09%), 9 Buy (81.82%), 1 Hold (9.09%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).
Buy
NKTX Price Target Upside V Benchmarks
Type | Name | Upside |
---|---|---|
Stock | Nkarta | 1030.89% |
Sector | Healthcare Stocks | 23.68% |
Industry | Biotech Stocks | 64.77% |
Price Target Trends
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | - | - |
Avg Price Target | - | - | - |
Last Closing Price | $1.91 | $1.91 | $1.91 |
Upside/Downside | - | - | - |
Ratings Trends
Date | Strong Buy | Buy | Hold | Sell | Strong Sell | Total |
---|---|---|---|---|---|---|
Jun, 25 | 2 | 4 | 1 | - | - | 7 |
May, 25 | 2 | 6 | - | - | - | 8 |
Apr, 25 | 2 | 6 | - | - | - | 8 |
Mar, 25 | 2 | 6 | - | - | - | 8 |
Feb, 25 | 2 | 6 | - | - | - | 8 |
Analyst Price Target Forecasts
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Mar 26, 2024 | Bill Maughan | Canaccord Genuity | $16.00 | $9.61 | 66.49% | 737.70% |
Mar 22, 2024 | Gil Blum | Needham | $15.00 | $12.98 | 15.56% | 685.34% |
Mar 22, 2024 | Salim Syed | Mizuho Securities | $25.00 | $8.92 | 180.27% | 1208.90% |
Mar 22, 2024 | Laura Prendergast | Raymond James | $16.00 | $8.92 | 79.37% | 737.70% |
Apr 26, 2022 | Raymond James | $32.00 | $18.72 | 70.94% | 1575.39% | |
Apr 26, 2022 | H.C. Wainwright | $36.00 | $18.72 | 92.31% | 1784.82% |
Analyst Rating Forecasts
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
May 15, 2025 | William Blair | Market Perform | downgrade | |
Oct 09, 2024 | Rodman & Renshaw | Buy | initialise | |
Aug 14, 2024 | Raymond James | Outperform | Strong Buy | upgrade |
Jun 28, 2024 | H.C. Wainwright | Buy | Buy | hold |
Mar 26, 2024 | Canaccord Genuity | Buy | Buy | hold |
Mar 22, 2024 | Barclays | Buy | Buy | hold |
Mar 22, 2024 | Raymond James | Strong Buy | Outperform | downgrade |
Oct 17, 2023 | Raymond James | Strong Buy | upgrade | |
Mar 17, 2023 | Credit Suisse | Buy | Buy | hold |
Dec 22, 2022 | Oppenheimer | Outperform | Perform | downgrade |
Financial Forecast
EPS Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-2.40 | $-1.60 | - | - | - | - |
Avg Forecast | $-2.37 | $-1.80 | $-1.78 | $-1.83 | $-2.11 | $-1.63 |
High Forecast | $-2.26 | $-1.72 | $-1.58 | $-1.44 | $-1.94 | $-1.63 |
Low Forecast | $-2.59 | $-1.86 | $-2.16 | $-2.35 | $-2.43 | $-1.63 |
Surprise % | 1.27% | -11.11% | - | - | - | - |
Revenue Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | - | - | - | - | - | - |
Avg Forecast | - | - | - | $2.25M | $5.33M | $74.95M |
High Forecast | - | - | - | $2.25M | $5.33M | $74.95M |
Low Forecast | - | - | - | $2.25M | $5.33M | $74.95M |
Surprise % | - | - | - | - | - | - |
Net Income Forecast
Annual
Dec 23 | Dec 24 | Dec 25 | Dec 26 | Dec 27 | Dec 28 | |
---|---|---|---|---|---|---|
Reported | $-117.50M | $-108.79M | - | - | - | - |
Avg Forecast | $-117.50M | $-87.89M | $-91.84M | $-92.98M | $-107.08M | $-79.99M |
High Forecast | $-110.75M | $-84.48M | $-77.59M | $-70.78M | $-94.87M | $-79.99M |
Low Forecast | $-126.77M | $-91.31M | $-106.08M | $-115.18M | $-119.29M | $-79.99M |
Surprise % | - | 23.77% | - | - | - | - |